Act No 366 / 2021 Coll.
Act amending Act No. 167 / 1998 Coll., on addictive substances and amending certain other laws, as amended, Act No. 378 / 2007 Coll., on Medicines and Amendments to Certain Related Acts (Act on Medicines), as amended, and Act No. 634 / 2004 Coll., on Administrative Charges, as amended
Valid
Law
Effective from 01.01.2022
Text versions:
01.01.2022
08.10.2021
Zobrazeno prvních 200 z celkem 584 ustanovení tohoto předpisu.
Zobrazit celý předpis →
Pro stažení celého znění použijte tlačítko Stáhnout výše.
366
THE LAW
of 14 September 2021
amending Act No 167 / 1998 Coll., on addictive substances and amending certain other laws, as amended, Act No 378 / 2007 Coll., on medicines and on amendments to certain related laws (Act on Medicines), as amended, and Act No 634 / 2004 Coll., on administrative fees, as amended
Parliament has decided on this law of the Czech Republic:
Amendment to the REC
Act No. 167 / 1998 Coll., on addictive substances and amending certain other laws, as amended by Act No. 354 / 1999 Coll., Act No. 117 / 2000 Coll., Act No. 132 / 2000 Coll., Act No. 57 / 2001 Coll., Act No. 185 / 2001 Coll., Act No. 135 / 2013 Coll., Act No. 140 / 2002 Coll., Act No. 140 / 2009 Coll., Act No. 141 / 2009 Coll., Act No. 167 / 2012 Coll., Act No. 50 / 2013 Coll.
1. in Paragraph 2 (a):
"(a) addictive substances of narcotic substances and psychotropic substances of natural or synthetic origin which have a psychoactive effect while being listed in one of the Annexes 1 to 7 to the Government Ordinance on the List of Addictive Substances, with the exception of hemp extract and tincture, which contains a maximum of 1% of the tetrahydrocaninol group substances and fulfils the safety condition of the General Product Safety Act,";
2. In Article 2 (b), the words "under the drug law 'are deleted and the words" except for a solution or mixture containing cannabis extract and tincture containing not more than 1% of the substances of the tetrahydrocaninol group are added at the end of the text of the letter. the substance cannabis extract and tincture must contain the solution or mixture in such a quantity that it cannot be misused or easily available or economically extracted from the solution or mixture. Such a solution or mixture shall comply with the safety condition of the General Product Safety Act,'.
3. in Article 2, the following points (e) to (h) are inserted after point (d), including footnote 2f:
"(e) hemp for the therapeutic use of hemp which is intended by the manufacturer for therapeutic purposes in humans or for processing for that purpose;
(f) a hemp plant for therapeutic use of a hemp plant grown for the production of hemp for therapeutic use;
(g) a plant of technical hemp, a plant of the genus hemp, from which hemp containing not more than 1% of the substances of the tetrahydrocaninol group may be obtained, or from seeds of the varieties listed in the Common Catalogue of Varieties of Agricultural Plant Species (2f), and technical hemp from a plant of technical hemp,
(h) the production of cannabis by a process consisting in the extraction of cannabis from a hemp plant;
(f) Council Directive 2002 / 53 / EC on the common catalogue of varieties of agricultural plant species. Council Directive 2002 / 57 / EC on the marketing of seed of oil and fibre plants, as amended. '
Points (e) and (f) shall be renumbered as points (i) and (j).
4. In Article 2, at the end of point (j), the dot is replaced by a comma and the following point (k) is added, including footnote 2g:
"(k) cannabis extract for therapeutic use of extract produced from cannabis for therapeutic use intended for the preparation of individually prepared medicinal production2g) under the conditions of good manufacturing practice of manufacturers of active substances under the Drug Act,
2g) Decree No. 236 / 2015 Coll., laying down the conditions for the prescription, preparation, distribution, supply and use of individually prepared cannabis-containing medicinal products for therapeutic use, as amended by Decree No. 307 / 2020 Coll. '
5. In Article 2, the current text becomes paragraph 1 and the following paragraph 2 is added:
"(2) The implementing legislation for cannabis extracts for therapeutic uses sets out the methods of production of cannabis extract for therapeutic uses, the analytical methods used to test active substances, the conditions for labelling and storage of cannabis extract for therapeutic uses, as well as the method of processing it as an feedstock when preparing individually prepared medicinal products under the Drug Act. '
6. In Paragraph 3 (1), the words "and cannabis production 'shall be added at the end of the text in point (a).
7. In Article 5 (1) (c), "pharmacists' is replaced by" pharmacists' and "pharmacist 'is replaced by" pharmacists'.
8. in Article 5 (2) (a), the words "or persons operating establishments providing social services of residence" shall be deleted;
9. in Article 5 (2) (c), the words "in health and social services establishments" shall be deleted;
10. in Article 5 (2) (f):
"(f) prepare and supply pharmacists at the pharmacy on the basis of a prescription,"
11. in Article 5 (2) (g), the word "pharmacists" is replaced by the word "pharmacists" and the word "pharmacist" is replaced by "pharmacist."
12. in Article 5 (2) (h):
"(h) for own use:
1. acquire, including on a representative basis, on the basis of a recipe issued under the Drug Act (hereinafter referred to as the "recipe") natural persons,
2. acquire natural persons on the basis of equipment provided by the health service provider under the Law on Medicines,
3. to acquire, in the case of authorised medicinal products containing a scheduled substance, category 1 under the conditions laid down in the marketing authorisation, a natural person,
4. store and use according to the prescription issued or by the doctor of the natural person, '.
13. in Article 5, at the end of paragraph 2, the dot is replaced by a comma and the following point (l) is added:
"(l) to store persons operating facilities providing residential social services.";
14. Paragraph 5 (5) reads:
"(5) No authorisation shall be required for the treatment of plants of technical hemp or of technical hemp, in particular for industrial, food, cosmetic, technical or garden purposes. ';
15. in Article 5, the following paragraph 11 is added:
"(11) Products containing addictive substances listed in Annex 2, 6 or 7 to the Government Ordinance on the list of addictive substances may be issued by pharmaceutical assistants at a pharmacy without authorisation on the basis of a request issued by a doctor under the Drug Act (hereinafter referred to as" the requisition ').'.
16. In Article 8, at the end of paragraph 1, the words "or the intended purpose of the treatment of addictive substances or preparations is contrary to § 3 (2) or to the public interest protected by this law or to an international agreement governing the treatment of addictive substances to which the Czech Republic is bound 'shall be added.
17. in Article 8 (5), the word "entrepreneur" shall be deleted after the word "or" and the word "entrepreneur" shall be deleted.
18. in Paragraph 8 (6), at the end of the text referred to in point (a), the words "where the treatment of addictive substances contained in medicinal products and medicinal substances is the subject of an application under the Drug Act (6)," shall be added.
19. in Paragraph 8 (6) (g), the words "responsible persons" and the words "18" shall be replaced by "§ 9 (4)";
20. in Paragraph 8 (6) (h), the words "responsible persons" shall be inserted after the word "eligibility."
21. in Paragraph 8 (9) (b), the word "v" and the words "and the person's identification number" shall be deleted;
22. In Article 8 (10), the first sentence is deleted and at the end of the text of the paragraph the sentence "The holder of a treatment permit which has been withdrawn may apply for a new treatment permit not earlier than two years after the date on which the decision to withdraw the treatment permit was taken. This shall apply mutatis mutandis to a legal person whose statutory authority is the person who was the statutory authority of the holder of the authorisation for treatment at the time when the authorisation for treatment was withdrawn. ';
23. In Paragraph 8a (1), the words "business' are inserted after the words" business', the words "permanent residence in the Czech Republic 'are replaced by the words" registered in the Czech Republic', the words "permanent residence or 'and the words" permanent residence or residence permit' are deleted; the comma after the word "administration 'is replaced by the words" or' and the words' or organisational component 'are deleted.
24. in § 8a (3) (a), the words "the extract must be accompanied by an annex to the Code of Criminal Procedure" shall be added at the end of the text in point 2.
25. The heading of Section 13 reads: "Prescription and supply of medicinal products containing highly addictive substances."
26. Paragraph 13 (1), including footnote 17, reads:
"(1) A medicinal product containing an addictive substance listed in Annex 1 or Annex 5 to the Government Ordinance on a list of addictive substances which is not listed in Annex 8 to the Government Ordinance on the list of addictive substances may be prescribed by the physician and issued by the pharmacist only to:
(a) a recipe produced in electronic form (the "electronic recipe") marked "highly addictive substance,"
(b) a recipe with a blue stripe drawn up in paper form, in exceptional cases where the conditions laid down by the Law on Medicinal Products (17) are met, for the issue of a recipe in paper form; a recipe with a blue stripe cannot be prescribed and issued with a cannabis-containing medicinal product for therapeutic use; or
(c) a request with a blue stripe displayed in paper form.
17) § 81f of Act No. 378 / 2007 Coll., as amended. '
footnote 6a is deleted.
27. In Paragraph 13, the following paragraphs 2 and 3 are inserted after paragraph 1:
"(2) In the case referred to in paragraph 1 (a) or (b), the physician, when prescribing the medicinal product and the pharmaceuticals at the dispensary, shall be required to instruct the patient or the person representing the patient in an appropriate manner on the fact that a medicinal product containing a highly addictive substance is prescribed and issued.
(3) A medicinal product containing an addictive substance listed in Annex 1 or 5 to the Government Ordinance on a list of addictive substances not listed at the same time in Annex 8 to the Government Ordinance on the list of addictive substances may be prescribed for the treatment of animals by a veterinarian solely for the provision of veterinary care and a pharmacist issued at a pharmacy only on:
(a) a recipe with a blue stripe displayed in paper form, or
(b) a request with a blue stripe displayed in paper form. ';
Paragraphs 2 to 11 shall be renumbered paragraphs 4 to 13.
28. In Paragraph 13, the sentence "Recipes and blue-striped vouchers are issued in the form of forms. 'is inserted at the beginning of paragraph 4.
29. in Article 13 (6), the word "forms" shall be inserted after the word "distribution."
30. Paragraph 13 (11) reads:
"(11) The implementing act provides for:
(a) the model of the blue stripe recipe, which is displayed in paper form, and the model of the blue stripe demand, which is displayed in paper form,
(b) the particulars given on the blue-striped recipe, which shall appear in the paper form referred to in paragraph 1, its period of validity and the rules governing its use;
(c) the particulars indicated on requests with a blue stripe, which shall appear in paper form in accordance with paragraph 1, its period of validity and the rules governing its use;
(d) the rules and method of distribution, record keeping, return and disposal of recipes and blue stripe requests;
(e) the data on the blue-striped recipe, which shall be presented in paper form in accordance with paragraph 3, its period of validity, restrictions on the type and quantity of medicinal products for the treatment of animals prescribed therein and the rules for its use;
(f) data supplied on demand with a blue stripe, which shall be made available in paper form in accordance with paragraph 3, its period of validity, restrictions on the type and quantity of medicinal products for the treatment of animals prescribed therein and the rules for its use. ";
footnote 6b is deleted.
31. in Paragraph 13, paragraph 12 is deleted;
Paragraph 13 shall become paragraph 12.
32. in Article 13 (12), the words "and the Ministry of Finance" shall be replaced by the words "issues," the words "theirs" shall be replaced by the words "its," the words "relevant," the words "2 to 8" shall be replaced by "4 to 10" and the words "or the Ministry of Finance" shall be deleted.
33. In Paragraph 14, the sentence "This shall not apply to plant waste resulting from the treatment of plants of technical hemp and of technical hemp shall be added at the end of paragraph 4. '.
34. In Paragraph 14, the following paragraph 5 is added:
"(5) A person treating cannabis for medical use on the basis of a treatment permit or a person treating cannabis for therapeutic use on the basis of Article 5 shall be obliged to dispose of cannabis for therapeutic use in accordance with paragraphs 1 and 2 no later than 4 months after the date on which it became inapplicable; This does not apply to the treatment of cannabis for therapeutic use in the form of reference samples under the conditions laid down in the Drug Act. Cannabis for therapeutic use shall become inapplicable on the day following the expiry date laid down by the manufacturer or on the day on which the event occurred that led to cannabis for therapeutic use not being used for legally authorised purposes. '
35. in Article 20 (2), the words "this shall not apply to medicinal products containing a scheduled substance of category 1, which are a substance listed in category 4 under the directly applicable European Union Regulation on the export of drug precursors to third countries (18); in such a case, an export authorisation is required under this directly applicable European Union Regulation (18); the issue of an export permit shall be subject to the law governing activities involving drug precursors'.
Footnote 18 reads:
"(18) Council Regulation (EC) No 111 / 2005 of 22 December 2004 laying down rules for the monitoring of trade in drug precursors between the Community and third countries, as amended."
36. in Paragraph 20 (2) (e):
"(e) to export plants of technical hemp and of technical hemp.";
37.Paragraph 20 (5) reads:
"(5) When exporting addictive substances and preparations from the territory of the Czech Republic to a Member State other than the European Union, one copy of the export authorisation shall be transmitted to the customs office which decides to place the goods in the consignment under the proposed customs procedure. The customs office shall indicate the goods in the consignment on the copy of the export authorisation and send it to the Ministry of Health. ';
38. in Paragraph 21 (2) (d):
"(d) imports of plants of technical hemp and of technical hemp,"
39. in Paragraph 21 (3):
"(3) On importation of addictive substances and preparations in the territory of the Czech Republic from a Member State other than the European Union, the customs office which decides to release the goods in the consignment shall indicate on the copy of the import authorisation the goods in the consignment and the date of release and send them to the Ministry of Health. '
40. Paragraph 22 (5) and (6) read:
"(5) When exporting addictive substances and preparations from the territory of the Czech Republic to a Member State other than the European Union, the customs declaration for placing goods under the customs export procedure shall be presented in accordance with Article 20 (5), including the export authorisation, if it is required to be issued under this law.
(6) On importation into the territory of the Czech Republic of addictive substances and preparations from a Member State other than the European Union, the customs declaration for the placing of goods under the customs procedure for free circulation or the special customs procedure shall be presented in accordance with Paragraph 21 (3) of this Act, including the import authorisation if it is to be issued under this law. '
41. in Paragraph 22 (7) (a), the words "international agreements by which" are replaced by "international agreements by which."
(42) In Article 24 (1) (a), the words "other" and the words "which may contain more than 0,3% of the substances of the tetrahydrocaninol group" shall be inserted after the words "other" and "which may contain more than 0,3% of the substances of the tetrahydrocaninol group," shall be replaced by the words "other than the plants of technical hemp."
43. In Article 24 (1), at the end of the text in point (b), the words "the prohibition shall not apply to cultivation for research and experimental purposes, for the breeding of new plant varieties and for the conservation of plant genetic diversity by scientific and research centres, as well as for ornamental purposes by botanical gardens and arborets," shall be added.
44. in Article 24 (1), the words "and for ornamental purposes, botanical gardens and arborets" shall be added at the end of the text in point (c).
45.
Cannabis for therapeutic use
Cannabis for therapeutic use must meet the conditions laid down for its use for the preparation of an individually prepared medicinal product containing cannabis for therapeutic use under the legislation governing the conditions for prescription, preparation, distribution, supply and use of individually prepared medicinal products containing cannabis for therapeutic use.
Growing cannabis plants for therapeutic use
(1) Only legal or business natural persons holding cannabis plants for therapeutic use may grow
(a) licences for the cultivation of hemp plants for therapeutic use; and
(b) authorisations for the treatment of addictive substances and preparations for cannabis treatment activities for therapeutic use.
(2) A licence for the cultivation of hemp plants for therapeutic use is granted by the State Institute for Drug Control on application, subject to compliance with the conditions laid down by this Law.
(3) The application referred to in paragraph 2 shall include, in addition to the general procedural requirements laid down in the administrative rules, the following:
(a) the total area of the growing plant; the cultivation plant for the purposes of this Part of the Act means the covered areas in which cultivation, production and all activities related to cultivation take place,
(b) the parcel number and the name of the cadastral territory of the parcel on which the growing plant is situated; and
(c) the area of the growing plant intended for growing hemp plants for therapeutic use.
(4) The application referred to in paragraph 2 shall include:
(a) a declaration of compliance with the conditions of good cultivation practice for growing hemp plants for therapeutic use;
(b) a document proving the legal reason for the use of the growing plant;
(c) a document containing the consent of the breeder to the activities specified in the application if the applicant is not the owner of the grower;
(d) proof of the integrity of the applicant and of the persons authorised to act on behalf of the applicant in accordance with Paragraph 8a (3); and
(e) proof of the lodging of an advance payment for expenses for professional activities carried out on request pursuant to § 24g.
(5) Furthermore, the application referred to in paragraph 2 shall include:
(a) an internal regulation for activities relating to the cultivation of hemp plants for therapeutic use containing at least:
1. the identification of persons having access to the grow house and under what conditions;
2. means of access to the grow house;
3. Means of handling keys or other means of entering the grow house,
4. the treatment of cannabis plants for therapeutic use and plant waste; plant waste for the purposes of this Part of the Act means waste arising from the cultivation of hemp plants for therapeutic use, hemp plants for therapeutic use, unless they have been used for the production of hemp or hemp for therapeutic use which has not met the quality requirements under the legislation governing the conditions for prescription, preparation, distribution, supply and use of individually prepared medicinal products containing cannabis for therapeutic use,
(b) documents demonstrating the applicant's readiness to grow hemp plants for therapeutic use, at least a dossier containing a technical description
1. equipment used for the cultivation, harvesting and processing of hemp plants for therapeutic use;
2. the cultivation security system; and
3. the construction of a growing plant providing protection against birds, insects, rodents and domestic animals; and
(c) photo-documenting of growing rooms and facilities intended for the cultivation, storage and processing of hemp plants for therapeutic use in the range of at least one photograph of each room and one external view.
(6) The applicant must already have a growing plant ready for growing hemp plants for therapeutic use at the time of application; the cultivation plant shall contain at least:
(a) establishments used for the proper cultivation, harvesting and processing of hemp plants for therapeutic use which comply with the rules of good cultivation practice for the cultivation of hemp plants for therapeutic use; and
(b) plant protection equipment in accordance with the rules of good cultivation practice for growing hemp plants for therapeutic use.
(7) The rules of good growing practice for growing hemp plants for therapeutic use shall be laid down in implementing legislation.
(8) The State Institute for Drug Control shall reject an application for a licence for the cultivation of hemp plants for therapeutic use submitted by the applicant for a licence for the cultivation of hemp for therapeutic use by a decision of the State Institute for Drug Control, provided that the decision to withdraw the licence has not expired for at least 1 year from the date on which the decision to withdraw the licence was taken. ';
46. The following Sections 24c to 24g are inserted after Section 24b, including the headings:
Licences for growing hemp plants for therapeutic use
(1) The licence for growing cannabis plants for therapeutic use is granted by the State Institute for Drug Control. The decision to grant the licence may be taken only after examination by the State Institute for Drug Control. A decision on an application for a licence shall be taken within 30 days of the date on which the application is submitted. In addition to the general elements of the decision under the administrative rules, the decision to grant the licence shall contain the information referred to in Article 24b (3).
(2) Licences for growing hemp plants for therapeutic use are granted for a period of 5 years. The validity of the licence may be extended. The licence shall not be transferred to the successor in title.
(3) If a person who has been granted a licence to grow hemp plants for therapeutic use whose validity ends, wishes to continue growing hemp plants for therapeutic use, he must submit to the State Institute for Drug Control an application for renewal of the licence granted no later than 6 months before the date of expiry of the licence. This application shall include an annex pursuant to Article 24b (4) (e) and an affidavit stating that there have been no changes in relation to the conditions under which the licence was granted. The validity of a licence for the cultivation of cannabis plants for therapeutic use may be extended by a maximum of 5 years by the State Institute for Drug Control.
(4) Any changes to the information contained in the licence for the cultivation of hemp plants for therapeutic use shall be required to inform the State Institute for Drug Control immediately in writing the person who has been granted the licence for the cultivation of hemp plants for therapeutic use.
(5) In the event of a change in the data contained in the licence for the cultivation of hemp plants for therapeutic use concerning:
(a) the total area of the growing plant indicated,
(b) the parcel or cadastral territory of the parcel on which the growing plant is situated;
(c) the area of the growing plant; or
(d) the name, registered office or legal form;
the person licensed must submit to the State Institute for Drug Control an application for the amendment of the licence for the cultivation of hemp plants for therapeutic use concerning that change no later than 15 days after the date of the change. The application for amendment of the licence shall contain, in addition to the particulars of the submission in accordance with the administrative rules, the particulars to be changed in the licence. The licence amendment application shall include the annexes referred to in § 24b (4) and (5) showing the required amendment. The period of validity of the amended licence shall be without prejudice to the decision to amend the licence. In the case of the information referred to in points (a) to (c), the decision to amend the licence shall be taken only after the examination referred to in paragraph 1 has been carried out and no later than 30 days after the date of submission of the application. An activity within the scope of the amendments contained in the licence amendment application shall not be authorised by the licence holder until the decision of the State Institute for Drug Control on the amendment of the licence for the cultivation of hemp plants for therapeutic use has become final.
(6) The facts which the State Institute for Drug Control has learned in connection with the procedure for granting, extending, amending, withdrawing or withdrawing a licence for the cultivation of hemp plants for therapeutic use must not be disclosed to other persons without the consent of the applicant, even under a law governing free access to information. Information that an application for the grant, extension or amendment of a licence for the cultivation of hemp plants for therapeutic use has been submitted may be published before the end of the procedure only with the consent of the applicant.
(7) If the validity of a licence for the cultivation of hemp plants for medical use pursuant to Article 24e (4) (c) is cancelled, the person holding the licence may apply for a new licence for the cultivation of hemp plants for therapeutic use not earlier than two years after the date on which the decision to withdraw the licence became final. This applies mutatis mutandis to a legal person whose statutory authority is the person who was the statutory authority of the holder of a licence for the cultivation of hemp for medical use at the time when the licence expired pursuant to Article 24e (4) (c).
Obligations of the holder of a licence for the cultivation of hemp plants for therapeutic use
The person licensed to grow hemp plants for therapeutic use shall:
(a) to ensure the cultivation of hemp plants for therapeutic use, the production of hemp and other activities related to cultivation in the growing plant referred to in the licence;
(b) ensure that the grow plant is secured by the introduction of a secure storage system, camera system and other security measures, at least to the extent provided for in the implementing legislation;
(c) ensure that all activities relating to the cultivation, harvesting and processing of hemp plants for the therapeutic use and disposal of plant waste referred to in (e) are recorded and recorded; the manner and extent of the reporting and registration shall be laid down in the implementing legislation;
(d) grow hemp plants for therapeutic use in accordance with good growing practice for growing hemp plants for therapeutic use;
(e) ensure that all plant waste is kept in the manner set out in paragraphs 1 to 3, mutatis mutandis, and disposed of at its own expense, in accordance with paragraph 14 (3), no later than 120 days after the date on which plant waste was generated,
(f) the treatment of cannabis plants for therapeutic use is subject to Sections 17, 18 and 19 (2) mutatis mutandis.
Termination of a licence for growing hemp plants for therapeutic use
(1) The State Institute for Drug Control will decide whether to withdraw a licence for the cultivation of hemp plants for therapeutic use or to reject an application for renewal of the licence if the holder of the licence has been found to be guilty of an infringement under this law, for which the upper limit of the fine is set at CZK 10 000 000, or of committing several offences under this law or of the repeated committing of an infringement under this law. The State Institute for Drug Control shall decide on the withdrawal of the licence if the holder of the licence has been convicted of a intentional or negligent offence the nature of which is linked to the treatment of addictive substances or preparations.
(2) Where a person who has been granted a licence to grow hemp plants for therapeutic use ceases to pursue the activity of growing hemp plants for therapeutic use, he shall notify the State Institute for Drug Control, which shall revoke the licence to grow hemp plants for therapeutic use within 15 days of the end of that activity. The State Institute for Drug Control shall decide to revoke the licence for the cultivation of hemp plants for therapeutic use also where the cessation of the activity of the cultivation of hemp plants for therapeutic use is detected by the licence holder in the course of his activity.
(3) If the State Institute for the Control of Drugs decides to withdraw or revoke a licence for the cultivation of hemp plants for therapeutic use or to refuse an application for renewal of a licence, the person who has been withdrawn or refused an application for renewal of a licence shall be obliged to dispose of his / her costs in accordance with the procedure laid down in Article 14 (3) no later than 30 days after the date of the decision or, in the case of refusal of an application for renewal of a licence, 30 days after the date of expiry of the licence.
(4) The validity of the licence for the cultivation of hemp plants for therapeutic use expires
(a) 90 days after the date on which the decision to grant a licence for the cultivation of hemp for medical use becomes final, unless the licence holder receives within that period a final decision to authorise the treatment of addictive substances and preparations for the treatment of cannabis for therapeutic use;
(b) the expiry of the period for which it was issued;
(c) a decision to withdraw a licence for the cultivation of hemp plants for therapeutic use,
(d) the decision to revoke the licence for the cultivation of hemp plants for therapeutic use,
(e) the disappearance or death of a person licensed to plant hemp for therapeutic use;
(f) the expiry of authorisations for the treatment of addictive substances and preparations for cannabis treatment activities for therapeutic use.
(5) Where the validity of a licence for the cultivation of hemp plants for therapeutic uses referred to in paragraph 4 (b) is cancelled. (b) or (f), the person holding this licence shall, at his expense, dispose of the growing material and plant waste in accordance with the procedure laid down in Article 14 (3) no later than 30 days after the expiry of the validity of the licence for the cultivation of hemp plants for therapeutic use or, in the event of the expiry of the authorisation for treatment, from the date on which the authorisation for treatment expired.
Repayment of expenses for carrying out professional tasks
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Act No. 366 / 2021 Coll., amending Act No. 167 / 1998 Coll., on addictive substances and amending certain other laws, as amended, Act No. 378 / 2007 Coll., on Medicines and Amendments to Certain Related Acts (Act on Medicines), as amended, and Act No. 634 / 2004 Coll., on Administrative Charges, as amended |
|---|---|
| Regulation Type | Law |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 08.10.2021 |
|---|---|
| Effective from | 01.01.2022 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0